South Africa ‘can’t afford’ to pay for new anti-HIV drug, despite cut-price offer | Global development | The Guardian
https://www.theguardian.com/global-development/2023/nov/17/south-africa-hiv-cab-la-cabotegravir-viiv-healthcare

#SouthAfrica
#HIV
#AntiHIVDrug
#Cabotegravir
#CABLA
#Pepfar
#ViiV
#Cipla